ZIOPHARM Oncology, Inc. Gains 33.33%
Tue, Sep 07, 2021 at 05:30 PM
ZIOPHARM Oncology, Inc. (ZIOP:NASDAQ) shot up at $2.2, a gain of 33.3%. The stock appeared on our News Catalysts scanner on Tue, Sep 07, 2021 at 10:56 AM in the 'INSIDER' category. From Fri, Aug 20, 2021, the stock recorded 50.00% Up Days and 54.55% Green Days
The stock spiked on Wed, Jun 09, 2021 at $3.73 with a volume of 7M+, and its share price has been moving sideways in recent weeks.
About ZIOPHARM Oncology, Inc. (ZIOP:NASDAQ)
ZIOPHARM Oncology Inc is a biotechnology company which acquires, develops, and commercializes cancer therapies that can address unmet medical needs through synthetic biology.
Top 10 Gainers:
- LWAC (LWAC:NASDAQ), 92.95%
- Mechel PAO (MTL:NYSE), 56.25%
- EFTR (EFTR:NASDAQ), 49.88%
- OG (OG:NYSE), 35.16%
- SRZN (SRZN:NASDAQ), 35.06%
- ZIOPHARM Oncology, Inc. (ZIOP:NASDAQ), 33.33%
- Adaptimmune Therapeutics plc (ADAP:NASDAQ), 28.95%
- LGL Systems Acquisition Corp. (DFNS:NYSE), 26.85%
- OPAD (OPAD:NYSE), 26.3%
- RNXT (RNXT:NASDAQ), 26.11%